BIOTECHNOLOGY IN THE PHARMACEUTICAL-INDUSTRY

[11] KLAUNER A, 1985, BIOTECHNOLOGY FEB, P119

[12] DERIVATION OF SPECIFIC ANTIBODY-PRODUCING TISSUE-CULTURE AND TUMOR LINES BY CELL-FUSION [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1976, 6 (07) : 511 - 519

[13] CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J]. NATURE, 1975, 256 (5517) : 495 - 497

[14] GROWTH-FACTORS, GROWTH-FACTOR RECEPTORS AND ONCOGENES [J]. BIO-TECHNOLOGY, 1985, 3 (02): : 135 - 140

[15] MILANESI G, 1984, BIOTECNOLOGIE ITALIA

[16] OBRIST R, 1983, TRENDS BIOTECHNOLOGY, V1, P375

[17] POWLEDGE TB, 1984, BIOTECHNOLOGY MAR, P214

[18] INTERLEUKIN-2 - THE MOLECULE AND ITS FUNCTION [J]. IMMUNOLOGY TODAY, 1984, 5 (07): : 203 - 209

[19] NEW FLUORINATED ERYTHROMYCINS OBTAINED BY MUTASYNTHESIS [J]. JOURNAL OF ANTIBIOTICS, 1983, 36 (11) : 1439 - 1450

[20] ULMER KM, 1983, SCIENCE, V219, P666, DOI 10.1126/science.6572017

[11] KLAUNER A, 1985, BIOTECHNOLOGY FEB, P119

[12] DERIVATION OF SPECIFIC ANTIBODY-PRODUCING TISSUE-CULTURE AND TUMOR LINES BY CELL-FUSION [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1976, 6 (07) : 511 - 519

[13] CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J]. NATURE, 1975, 256 (5517) : 495 - 497

[14] GROWTH-FACTORS, GROWTH-FACTOR RECEPTORS AND ONCOGENES [J]. BIO-TECHNOLOGY, 1985, 3 (02): : 135 - 140

[15] MILANESI G, 1984, BIOTECNOLOGIE ITALIA

[16] OBRIST R, 1983, TRENDS BIOTECHNOLOGY, V1, P375

[17] POWLEDGE TB, 1984, BIOTECHNOLOGY MAR, P214

[18] INTERLEUKIN-2 - THE MOLECULE AND ITS FUNCTION [J]. IMMUNOLOGY TODAY, 1984, 5 (07): : 203 - 209

[19] NEW FLUORINATED ERYTHROMYCINS OBTAINED BY MUTASYNTHESIS [J]. JOURNAL OF ANTIBIOTICS, 1983, 36 (11) : 1439 - 1450

[20] ULMER KM, 1983, SCIENCE, V219, P666, DOI 10.1126/science.6572017